Total amount raised
$276 Millions
Latest funding date
1/1/2025
Location
Hippocratic AI has successfully raised $278 million in funding, positioning itself as a significant player in the healthcare technology sector. The company specializes in developing safety-focused large language models for medical applications, ensuring evidence-based healthcare content is acquired through legal means.
Keep reading to explore the intricacies of Hippocratic AI's fundraising journey and the investors backing this innovative platform.
What Is Hippocratic AI?
Hippocratic AI, founded in April 2023, is a healthcare technology company based in Palo Alto, California. The company specializes in developing safety-focused large language models for non-diagnostic, patient-facing applications.
Founded by Alex Miller, Debajyoti Datta, Kim Parikh, Meenesh Bhimani, Munjal Shah, Saad Godil, Subhabrata Mukherjee, and Vishal Parikh, Hippocratic AI emphasizes acquiring evidence-based healthcare content through legal means.
With a team of 101-250 employees, the company is dedicated to ensuring the safety and reliability of its AI solutions in the healthcare sector.
How Much Funding Has Hippocratic AI Raised?
- Seed Round
- Amount Raised: $50M
- Date: May 2023
- Lead Investors: Andreessen Horowitz, General Catalyst
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the development of their AI technology and establish initial market presence.
- Seed Round
- Amount Raised: $15M
- Date: July 2023
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop their AI models and expand their team.
- Series A
- Amount Raised: $53M
- Date: March 2024
- Lead Investors: General Catalyst, Premji Invest
- Valuation at Round: $500M
- Motivation Behind the Round: To enhance their AI capabilities and secure initial contracts with health systems.
- Series A
- Amount Raised: $17M
- Date: September 2024
- Lead Investors: NVentures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To continue product development and expand market reach.
- Series B
- Amount Raised: $141M
- Date: January 2025
- Lead Investors: Kleiner Perkins
- Valuation at Round: $1.64B
- Motivation Behind the Round: To expand the product range, enter new markets, and improve AI technology.
Total Amount Raised: $276M. Current Valuation: $1.64B.
Key Investors
- Kleiner Perkins
- Details: Kleiner Perkins is a leading venture capital firm known for investing in early-stage and growth companies. They have a strong track record of backing transformative technology and life sciences companies.
- Investment Focus Areas: Technology, healthcare, life sciences.
- Notable Investments: Google, Amazon, Genentech.
- General Catalyst
- Details: General Catalyst is a venture capital firm that provides early-stage and growth equity investments. They focus on partnering with entrepreneurs to build innovative companies.
- Investment Focus Areas: Technology, healthcare, consumer sectors.
- Notable Investments: Airbnb, Stripe, Snap.
- Andreessen Horowitz
- Details: Andreessen Horowitz, also known as a16z, is a private venture capital firm that backs bold entrepreneurs building the future through technology. They have a significant presence in the tech industry.
- Investment Focus Areas: Technology, AI, healthcare.
- Notable Investments: Facebook, Twitter, Coinbase.
- Nvidia
- Details: Nvidia is a technology company renowned for its graphics processing units (GPUs) and AI computing. They invest in companies that can leverage their GPU technology.
- Investment Focus Areas: AI, gaming, data center technologies.
- Notable Investments: Graphcore, Cerebras Systems, DataRobot.
- Premji Invest
- Details: Premji Invest is the investment arm of Azim Premji, focusing on growth investments. They have a diverse portfolio across various sectors.
- Investment Focus Areas: Technology, healthcare, consumer sectors.
- Notable Investments: Flipkart, PolicyBazaar, FabHotels.
What's Next for Hippocratic AI?
Hippocratic AI stands at the cusp of a transformative journey, with vast opportunities in expanding its product range and entering new markets. The healthcare sector's need for AI solutions to address the global shortage of healthcare professionals is immense, and Hippocratic AI is well-positioned to capitalize on this demand. Their AI agents, designed for non-diagnostic, patient-facing tasks, offer a promising solution to improve chronic care management and post-discharge follow-up.
Future fundraising opportunities appear bright, with the potential for additional Series C or later-stage funding rounds. Strategic partnerships with healthcare providers and technology companies could further bolster their growth. However, challenges such as ensuring the safety and reliability of AI agents, navigating regulatory requirements, and facing competition from other AI and healthcare technology companies remain. As they scale operations, maintaining quality and effectiveness will be crucial.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Hippocratic AI and gather other critical business insights.
Sign up for free on Clay and unlock the potential to drive your sales efforts with unparalleled data and insights.
